Global Biomaterials Market Outlook 2019-2024 - $206+ Billion Opportunity Analysis Driven by Increasing Demand for Implantable Devices

Dublin, June 24, 2019 (GLOBE NEWSWIRE) -- The "Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural) & By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) -Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

The global biomaterials market is projected to reach USD 206.64 billion by 2024 from USD 105.18 billion in 2019, at a CAGR of 14.5% during the forecast period.

Growth in this market is primarily attributed to increasing funds and grants by government bodies and universities for the development of novel biomaterials, increasing demand for implantable devices, growing demand for biomaterials in plastic surgery and wound healing applications, rising incidences of cardiovascular diseases, and rising awareness and research on regenerative medicine.

However, stringent clinical & regulatory processes and unfavourable healthcare reforms in the US, limitations of biomaterial-based products, and shortage of skilled surgeons are expected to restrain the growth of this market during the forecast period.

North America dominated the global biomaterials market in 2018, with a share of 45%. The US is the largest market in North America, followed by Canada. Factors such as rising biomaterials-based research, growing demand for plastic surgeries, increase in cancer incidences, and the growing number of cardiovascular diseases are contributing to the growth of the biomaterials market in the US. In Canada, market growth is mainly driven by increasing funding for biomaterials and increasing R&D activity.

The Asia Pacific biomaterials market, comprising India, China, Japan, and the RoAPAC, is anticipated to offer growth opportunities for players in the biomaterials market. It accounted for 17.1% of the global biomaterials market in 2018 and is expected to grow at the highest CAGR of 18.1% during the forecast period. Japan's growing healthcare industry, increasing geriatric population, rising number of cosmetic and plastic surgeries in India, lucrative medical devices industry, and favourable tax policy in China are driving the growth of this biomaterials market.

Prominent players in the biomaterials market are Royal DSM (Netherlands), BASF SE (Germany), Corbion (Netherlands), Covestro AG (Germany), Carpenter Technology Corporation (US), Evonik Industries (Germany), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), Celanese Corporation (US), Coorstek Inc. (US), CeramTec (Germany), and Gelita AG (Germany).

Key Topics Covered

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology
2.1 Research Methodology Steps
2.2 Research Design
2.3 Secondary Data
2.4 Market Size Estimation Methodology
2.5 Market Data Validation and Triangulation
2.6 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Biomaterials Market Overview
4.2 Biomaterials Market, By Type, 2018 (USD Billion)
4.3 Biomaterials Market: Geographic Snapshot

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increased Funds & Grants By Government Bodies & Universities for the Development of Novel Biomaterials
5.2.1.2 Increasing Demand for Implantable Devices
5.2.1.3 Growing Demand for Biomaterials in Plastic Surgery & Wound Healing Applications
5.2.1.4 Rising Incidence of Cardiovascular Diseases
5.2.1.5 Increasing Research on Regenerative Medicine
5.2.2 Restraints
5.2.2.1 Stringent Clinical & Regulatory Processes
5.2.2.2 Unfavorable Healthcare Reforms in the US
5.2.3 Opportunities
5.2.3.1 Growing Healthcare Market in Emerging Economies
5.2.3.2 Increasing Number of Free-Trade Agreements
5.2.4 Challenges
5.2.4.1 Limitations of Biomaterial-Based Products
5.2.4.2 Shortage of Skilled Surgeons

6 Regulatory Assessment
6.1 Introduction
6.2 US
6.2.1 Introduction
6.2.2 FDA Device Classification
6.2.3 US: Regulatory Approval Timeline Assessment
6.2.4 Stringent FDA Regulations Governing Product Approvals
6.3 Canada
6.3.1 Introduction
6.3.2 Canada: Regulatory Approval Timeline Assessment
6.3.3 Health Canada Classification
6.4 Europe
6.4.1 Introduction
6.4.2 European Medical Device Classification
6.4.3 Europe: Regulatory Approval Timeline Assessment
6.4.4 European Regulatory Process to Get More Stringent in Future
6.5 Japan
6.5.1 Introduction
6.5.2 PMDA Device Classification
6.5.3 Japan: Regulatory Approval Timeline Assessment
6.5.4 Revision of the Pharmaceutical Affairs Law (PAL) and Implementation of the New PMD Act in Japan
6.6 China
6.6.1 Introduction
6.6.2 CFDA Device Classification
6.6.3 China: Regulatory Approval Timeline Assessment
6.6.4 Rising Hurdles in the Regulatory Process in China
6.7 India
6.7.1 Introduction
6.7.2 Indian Medical Devices Classification
6.8 Australia
6.8.1 Introduction
6.8.2 TGA Device Classification
6.8.3 Australia: Regulatory Approval Timeline Assessment

7 Biomaterials Market, By Type
7.1 Introduction
7.2 Metallic Biomaterials
7.2.1 Stainless Steel
7.2.1.1 Stainless Steel Dominates the Metallic Biomaterials Market
7.2.2 Titanium & Titanium Alloys
7.2.2.1 Rising Number of Joint Replacement Procedures Will Drive the Market for Titanium Biomaterials
7.2.3 Cobalt-Chrome Alloys
7.2.3.1 Low Cost and Excellent Corrosion Resistance have Driven the Use of Cobalt-Chrome Alloys
7.2.4 Gold
7.2.4.1 Expanding Applications of Gold Nanoparticles to Drive the Demand for Gold Biomaterials
7.2.5 Silver
7.2.5.1 Toxic Properties and Low Aesthetic Appeal Likely to Limit the Use of Silver in Biomaterial-Based Products
7.2.6 Magnesium
7.2.6.1 Biodegradable Characteristic of Magnesium have Stimulated the Growth of This Market Segment
7.3 Polymeric Biomaterials
7.3.1 Polymethylmethacrylate
7.3.1.1 Pmma Dominates the Polymeric Biomaterials Market
7.3.2 Polyethylene
7.3.2.1 Wear and Tear Resistance of Polyethylene have Made It Popular in Hip and Knee Joint Replacements
7.3.3 Polyester
7.3.3.1 Biodegradable Nature and Biocompatibility of Polyester Will Drive Its Use in Various Medical Applications
7.3.4 Polyvinylchloride
7.3.4.1 Heavy Chlorine Content of Pvc is Likely to Hamper the Market Growth
7.3.5 Silicone Rubber
7.3.5.1 Silicone Rubbers are Non-Reactive, Stable, and Resistant to Extreme Environments and Temperatures
7.3.6 Nylon
7.3.6.1 Nylon's Low Weight, Corrosion Resistance, and Wide Applications are Expected to Drive Market Demand
7.3.7 Polyetheretherketone
7.3.7.1 Peek is Gaining Popularity as A Viable Alternative to Metals
7.3.8 Other Polymeric Biomaterials
7.4 Ceramics
7.4.1 Calcium Phosphate
7.4.1.1 Calcium Phosphate Drives Ceramic Biomaterial Market Segment
7.4.2 Zirconia
7.4.2.1 Bio-Inertness and Low Wear Rate of Zirconia Will Boost the Market Growth
7.4.3 Aluminum Oxide
7.4.3.1 Increasing Use of Aluminum Oxide in Hip Replacements and Dental Implants to Drive the Market
7.4.4 Calcium Sulfate
7.4.4.1 Fast Resorption Rate of Calcium Sulfate is Likely to Hamper Its Use
7.4.5 Carbon
7.4.5.1 Increasing Use of Carbon Nanofibers in Regenerative Medicine and Cancer Treatment Will Drive Market Growth
7.4.6 Glass
7.4.6.1 Rising Number of Orthopedics and Dental Procedures Likely to Drive the Demand for Glass Biomaterials
7.5 Natural Biomaterials
7.5.1 Hyaluronic Acid
7.5.1.1 Rising Prevalence of Osteoarthritis to Drive Hyaluronic Acid Market
7.5.2 Collagen
7.5.2.1 Rising Prevalence of Target Applications to Drive Growth in Collagen Market
7.5.3 Gelatin
7.5.3.1 Low Cost of Gelatin to Drive Its Market Growth
7.5.4 Fibrin
7.5.4.1 Fibrin Biomaterials Were Among the First Used to Prevent Bleeding
7.5.5 Cellulose
7.5.5.1 Cellulose Find Applications in Wound Healing, Skin Regeneration, and Ophthalmology
7.5.6 Chitin
7.5.6.1 Chitin Accelerates Skin Regeneration and Possesses High Biocompatibility
7.5.7 Alginates
7.5.7.1 Various Applications of Alginates Include Wound Healing, Tissue Engineering & Regenerative Medicine, and Drug Delivery
7.5.8 Silk
7.5.8.1 The Flexibility, Glossiness, and Adhesive Abilities of Silk have Made It Popular in Cosmetic Applications

8 Biomaterials Market, By Application
8.1 Introduction
8.2 Cardiovascular
8.2.1 Catheters
8.2.2 Stents
8.2.3 Implantable Cardiac Defibrillators
8.2.4 Pacemakers
8.2.5 Sensors
8.2.6 Heart Valves
8.2.7 Vascular Grafts
8.2.8 Guidewires
8.2.9 Others
8.3 Orthopedic
8.3.1 Joint Replacement
8.3.1.1 Knee Replacement
8.3.1.2 Hip Replacement
8.3.1.3 Shoulder Replacement
8.3.1.4 Others
8.3.2 Viscosupplementation
8.3.3 Bioresorbable Tissue Fixation
8.3.3.1 Suture Anchors
8.3.3.2 Interference Screws
8.3.3.3 Meniscal Repair Tacks
8.3.3.4 Meshes
8.3.4 Spine
8.3.4.1 Spinal Fusion Surgeries
8.3.4.2 Minimally Invasive Fusion Surgeries
8.3.4.3 Motion Preservation & Dynamic Stabilization Surgeries
8.3.4.3.1 Pedicle-Based Rod Systems
8.3.4.3.2 Interspinous Spacers
8.3.4.3.3 Artificial Discs
8.3.5 Fracture Fixation Devices
8.3.5.1 Bone Plates
8.3.5.2 Screws
8.3.5.3 Pins
8.3.5.4 Rods
8.3.5.5 Wires
8.3.6 Synthetics Bone Grafts
8.4 Ophthalmology
8.4.1 Increasing Prevalence of Eye Diseases to Drive Market Growth
8.4.2 Contact Lenses
8.4.3 Intraocular Lenses
8.4.4 Functional Replacement of Ocular Tissues
8.4.5 Synthetic Corneas
8.4.6 Others
8.5 Dental
8.5.1 Synthetic Dental Biomaterials Include Metals, Ceramics, Polymers, and Composite Structures
8.5.2 Dental Implants
8.5.3 Dental Bone Grafts & Substitutes
8.5.4 Dental Membranes
8.5.5 Tissue Regeneration
8.6 Plastic Surgery
8.6.1 Growing Number of Cosmetic Surgeries Performed to Drive the Market for Biomaterials
8.6.2 Soft-Tissue Fillers
8.6.3 Craniofacial Surgery
8.7 Wound Healing
8.7.1 Biomaterials are Extensively Used in Various Wound Healing Products
8.7.2 Wound Closure Devices
8.7.2.1 Sutures
8.7.2.2 Staples
8.7.3 Surgical Hemostats
8.7.4 Internal Tissue Sealants
8.7.5 Adhesion Barriers
8.7.6 Hernia Meshes
8.8 Tissue Engineering
8.8.1 Increasing Demand for Enhanced Mechanical Performance of Tissue-Engineered Implants to Support the Growth of This Application Segment
8.8.2 Scaffolds for Regenerative Medicine
8.8.3 Nanomaterials for Biosensing
8.8.4 Tailoring of Inorganic Nanoparticles
8.9 Neurological/Central Nervous System Applications
8.9.1 The Major Application Areas of Biomaterials in Cns Disorders Include Shunting, Cortical Neural Prosthesis, and Neural Stem Cell Encapsulation
8.9.2 Shunting Systems
8.9.3 Cortical Neural Prosthetics
8.9.4 Hydrogel Scaffolds for Cns Repair
8.9.5 Neural Stem Cell Encapsulation
8.10 Other Applications
8.10.1 Drug Delivery Systems
8.10.2 Gastrointestinal Applications
8.10.3 Bariatric Surgery
8.10.4 Urinary Applications

9 Biomaterials Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 US Dominates the North American Biomaterials Market
9.2.2 Canada
9.2.2.1 Increasing Incidence of Cardiovascular Diseases to Drive Market Growth in Canada
9.3 Europe
9.3.1 Germany
9.3.1.1 Large Medical Devices Market to Support the Adoption of Biomaterials in Germany
9.3.2 UK
9.3.2.1 Availability of Funds and Rising Cardiovascular Procedures to Drive the Biomaterials Market in the UK
9.3.3 France
9.3.3.1 Rising Aging Population and Associated Diseases to Drive the Market in France
9.3.4 Spain
9.3.4.1 Increasing Research Activities on Biomaterials to Drive the Growth in Spain
9.3.5 Rest of Europe (RoE)
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 Growing Medical Devices Industry to Drive Market Growth
9.4.2 China
9.4.2.1 Lucrative Medical Devices Industry in China
9.4.3 India
9.4.3.1 Large Population Base and Growing Medical Tourism in India to Drive the Growth of Biomaterials
9.4.4 Rest of Asia Pacific (RoAPAC)
9.5 Rest of the World (RoW)

10 Competitive Landscape
10.1 Overview
10.2 Competitive Scenario
10.2.1 Product Launches
10.2.2 Mergers and Acquisitions
10.2.3 Expansions
10.3 Competitive Leadership Mapping (Overall Market) (2018)
10.3.1 Visionary Leaders
10.3.2 Innovators
10.3.3 Dynamic Differentiators
10.3.4 Emerging Companies
10.4 Competitive Leadership Mapping (Start-Up) (2018)
10.4.1 Progressive Companies
10.4.2 Starting Blocks
10.4.3 Dynamic Companies
10.4.4 Responsive Companies

11 Company Profiles
11.1 Royal DSM
11.2 BASF SE
11.3 Corbion
11.4 Covestro AG
11.5 Carpenter Technology Corporation
11.6 Evonik Industries
11.7 Berkeley Advanced Biomaterials Inc.
11.8 Cam Bioceramics B.V.
11.9 Celanese Corporation
11.10 CoorsTek Inc.
11.11 CeramTec GmbH
11.12 GELITA AG

For more information about this report visit https://www.researchandmarkets.com/r/ddzvan

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

                    CONTACT: ResearchAndMarkets.com
                             Laura Wood, Senior Press Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                    Related Topics: Biomaterials